SHIP1 Inhibition Increases Immunoregulatory Capacity and Triggers Apoptosis of Hematopoietic Cancer Cells
Brooks, Robert, Fuhler, Gwenny M, Iyer, Sonia, Smith, Michelle J, Park, Mi-Young, Paraiso, Kim H. T, Engelman, Robert W, Kerr, William G
Published in The Journal of immunology (1950) (01.04.2010)
Published in The Journal of immunology (1950) (01.04.2010)
Get full text
Journal Article
Induced SHIP Deficiency Expands Myeloid Regulatory Cells and Abrogates Graft-versus-Host Disease
Paraiso, Kim H. T, Ghansah, Tomar, Costello, Amy, Engelman, Robert W, Kerr, William G
Published in Journal of Immunology (01.03.2007)
Published in Journal of Immunology (01.03.2007)
Get full text
Journal Article
PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression
PARAISO, Kim H. T, YUN XIANG, RIBAS, Antoni, DALLA PALMA, Maurizia, NATHANSON, Katherine L, KOOMEN, John M, MESSINA, Jane L, SMALLEY, Keiran S. M, REBECCA, Vito W, ABEL, Ethan V, CHEN, Y. Ann, MUNKO, A. Cecilia, WOOD, Elizabeth, FEDORENKO, Inna V, SONDAK, Vernon K, ANDERSON, Alexander R. A
Published in Cancer research (Chicago, Ill.) (01.04.2011)
Published in Cancer research (Chicago, Ill.) (01.04.2011)
Get full text
Journal Article
Inappropriate Recruitment and Activity by the Src Homology Region 2 Domain-Containing Phosphatase 1 (SHP1) Is Responsible for Receptor Dominance in the SHIP-Deficient NK Cell
Wahle, Joseph A, Paraiso, Kim H. T, Kendig, Robert D, Lawrence, Harshani R, Chen, Liwei, Wu, Jerry, Kerr, William G
Published in The Journal of immunology (1950) (15.12.2007)
Published in The Journal of immunology (1950) (15.12.2007)
Get full text
Journal Article
Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma
Fedorenko, Inna V., Paraiso, Kim H.T., Smalley, Keiran S.M.
Published in Biochemical pharmacology (01.08.2011)
Published in Biochemical pharmacology (01.08.2011)
Get full text
Journal Article
The HSP90 Inhibitor XL888 Overcomes BRAF Inhibitor Resistance Mediated through Diverse Mechanisms
PARAISO, Kim H. T, HAARBERG, H. Eirik, JOHN, Jobin K, SARNAIK, Amod A, KOOMEN, John M, SMALLEY, Keiran S. M, WOOD, Elizabeth, REBECCA, Vito W, CHEN, Y. Ann, YUN XIANG, RIBAS, Antoni, LO, Roger S, WEBER, Jeffrey S, SONDAK, Vernon K
Published in Clinical cancer research (01.05.2012)
Published in Clinical cancer research (01.05.2012)
Get full text
Journal Article
Expansion of Myeloid Suppressor Cells in SHIP-Deficient Mice Represses Allogeneic T Cell Responses
Ghansah, Tomar, Paraiso, Kim H. T, Highfill, Steven, Desponts, Caroline, May, Sarah, McIntosh, Joseph K, Wang, Jia-Wang, Ninos, John, Brayer, Jason, Cheng, Fengdong, Sotomayor, Eduardo, Kerr, William G
Published in The Journal of immunology (1950) (15.12.2004)
Published in The Journal of immunology (1950) (15.12.2004)
Get full text
Journal Article
Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells
Beck, Daniela, Niessner, Heike, Smalley, Keiran S M, Flaherty, Keith, Paraiso, Kim H T, Busch, Christian, Sinnberg, Tobias, Vasseur, Sophie, Iovanna, Juan Lucio, Drießen, Stefan, Stork, Björn, Wesselborg, Sebastian, Schaller, Martin, Biedermann, Tilo, Bauer, Jürgen, Lasithiotakis, Konstantinos, Weide, Benjamin, Eberle, Jürgen, Schittek, Birgit, Schadendorf, Dirk, Garbe, Claus, Kulms, Dagmar, Meier, Friedegund
Published in Science signaling (29.01.2013)
Published in Science signaling (29.01.2013)
Get more information
Journal Article
Vertical inhibition of the MAPK pathway enhances therapeutic responses in NRAS-mutant melanoma
Rebecca, Vito W., Alicea, Gretchen M., Paraiso, Kim H. T., Lawrence, Harshani, Gibney, Geoffrey T., Smalley, Keiran S. M.
Published in Pigment cell and melanoma research (01.11.2014)
Published in Pigment cell and melanoma research (01.11.2014)
Get full text
Journal Article
Evaluating Melanoma Drug Response and Therapeutic Escape with Quantitative Proteomics
Rebecca, Vito W., Wood, Elizabeth, Fedorenko, Inna V., Paraiso, Kim H.T., Haarberg, H. Eirik, Chen, Yi, Xiang, Yun, Sarnaik, Amod, Gibney, Geoffrey T., Sondak, Vernon K., Koomen, John M., Smalley, Keiran S.M.
Published in Molecular & cellular proteomics (01.07.2014)
Published in Molecular & cellular proteomics (01.07.2014)
Get full text
Journal Article
GSK3β Inhibition Blocks Melanoma Cell/Host Interactions by Downregulating N-Cadherin Expression and Decreasing FAK Phosphorylation
John, Jobin K., Paraiso, Kim H.T., Rebecca, Vito W., Cantini, Liliana P., Abel, Ethan V., Pagano, Nicholas, Meggers, Eric, Mathew, Rahel, Krepler, Clemens, Izumi, Victoria, Fang, Bin, Koomen, John M., Messina, Jane L., Herlyn, Meenhard, Smalley, Keiran S.M.
Published in Journal of investigative dermatology (01.12.2012)
Published in Journal of investigative dermatology (01.12.2012)
Get full text
Journal Article
Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP
Collazo, Michelle M., Paraiso, Kim H. T., Park, Mi‐Young, Hazen, Amy L., Kerr, William G.
Published in European journal of immunology (01.07.2012)
Published in European journal of immunology (01.07.2012)
Get full text
Journal Article
SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation
Desponts, Caroline, Hazen, Amy L., Paraiso, Kim H.T., Kerr, William G.
Published in Blood (01.06.2006)
Published in Blood (01.06.2006)
Get full text
Journal Article
Cutting Edge: Dominance by an MHC-Independent Inhibitory Receptor Compromises NK Killing of Complex Targets
Wahle, Joseph A, Paraiso, Kim H. T, Costello, Amy L, Goll, Emily L, Sentman, Charles L, Kerr, William G
Published in The Journal of immunology (1950) (15.06.2006)
Published in The Journal of immunology (1950) (15.06.2006)
Get full text
Journal Article
Inhibition of HSP90 by AT13387 delays the emergence of resistance to BRAF inhibitors and overcomes resistance to dual BRAF and MEK inhibition in melanoma models
Smyth, Tomoko, Paraiso, Kim H T, Hearn, Keisha, Rodriguez-Lopez, Ana M, Munck, Joanne M, Haarberg, H Eirik, Sondak, Vernon K, Thompson, Neil T, Azab, Mohammad, Lyons, John F, Smalley, Keiran S M, Wallis, Nicola G
Published in Molecular cancer therapeutics (01.12.2014)
Published in Molecular cancer therapeutics (01.12.2014)
Get full text
Journal Article
Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype
Paraiso, Kim H T, Das Thakur, Meghna, Fang, Bin, Koomen, John M, Fedorenko, Inna V, John, Jobin K, Tsao, Hensin, Flaherty, Keith T, Sondak, Vernon K, Messina, Jane L, Pasquale, Elena B, Villagra, Alejandro, Rao, Uma N, Kirkwood, John M, Meier, Friedegund, Sloot, Sarah, Gibney, Geoffrey T, Stuart, Darrin, Tawbi, Hussein, Smalley, Keiran S M
Published in Cancer discovery (01.03.2015)
Published in Cancer discovery (01.03.2015)
Get full text
Journal Article
Inhibition of Wee1, AKT, and CDK4 underlies the efficacy of the HSP90 inhibitor XL888 in an in vivo model of NRAS-mutant melanoma
Haarberg, H Eirik, Paraiso, Kim H T, Wood, Elizabeth, Rebecca, Vito W, Sondak, Vernon K, Koomen, John M, Smalley, Keiran S M
Published in Molecular cancer therapeutics (01.06.2013)
Published in Molecular cancer therapeutics (01.06.2013)
Get full text
Journal Article
SHIP limits immunoregulatory capacity in the T-cell compartment
Collazo, Michelle M., Wood, Daniela, Paraiso, Kim H.T., Lund, Erin, Engelman, Robert W., Le, Cam-Tien, Stauch, Diana, Kotsch, Katja, Kerr, William G.
Published in Blood (26.03.2009)
Published in Blood (26.03.2009)
Get full text
Journal Article